HIV & Aging Clinical Recommendations

CME/CE Info

HIV & Aging Clinical Recommendations

HIV & Aging
Jointly provided by Postgraduate Institute for Medicine and American Academy of HIV Medicine
This activity is supported by an independent educational grants from Gilead, Merck and ViiV
Release date: June 8, 2021
Expiration date: June 8, 2022
Estimated time to complete activity: 14.25 hours
To contact PIM: www.pimed.com

Information that Must be Made Available to the Learner

 

WHO WILL BENEFIT

  • Physicians aspiring to provide better care for older adults with HIV
  • Nurse practitioners or physician assistants looking to create a niche in their practice for an emerging population
  • Clinics or organizations seeking to improve outcomes for older patients with HIV

Faculty

Amy Caroline Justice, MD, PhD – VA Connecticut Healthcare

Stephen Karpiak, PhD – Managing Director Center for HIV and Aging at GMHC

NathanWass, MD – Mount Auburn Hospital 

David Spach, MD – University of Washington School of Medicine, Division of Allergy and Infectious Diseases

Sarah Smith, MHS, PA-C – Philadelphia FIGHT!

Allison Webbel, PhD, RN – Case Western Reserve School of Nursing 

Kristina Crothers, MD – University of Washington Medical School, Division of Pulmonary, Critical Care, and Sleep Medicine  

Jeffrey Kwong, DNP, MPH, NP – Rutgers The State University of New Jersey, Schol of Nursing

Michael Ross, MD – Montefiore/Albert Einstein College of Medicine  

Molly Fisher, DO – Montefiore/Albert Einstein College of Medicine 

Mehul Tejani, MD – Emory University School of Medicine  

Meredith Greene, MD – University of California, San Francisco School of Medicine  

Brian Wood, MD – University of Washington School of Medicine, Division of Allergy and Infectious Diseases

Daniel Lee, MD – UC San Diego Health

James Scott, PharmD – Western University of Health Sciences

Brandon Samson, PharmD, MPW – Western University of Health Sciences  

Charlie Smigelski, BA, BS, RD

Marshall Forstein, MD – Harvard Medical School, Department of Psychiatry  

Pariya Fazeli Wheeler, PhD – University of Alabama, Birmingham

Karl Goodkind, MD, PhD – University of Nebraska College of Medicine  

David E. Vance, PhD, MGS – University of Alabama, Birmingham

 

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Amy Caroline Justice, MD, PhD – nothing to disclose

Stephen Karpiak, PhD – nothing to disclose

NathanWass, MD – nothing to disclose

David Spach, MD – nothing to disclose

Sarah Smith, MHS, PA-C – nothing to disclose

Allison Webbel, PhD, RN – nothing to disclose

Kristina Crothers, MD – nothing to disclose

Jeffrey Kwong, DNP, MPH, NP – fees for Non-CME/CE Services Directly from a Commercial Interest or their Agent: Gilead Sciences, Inc.

Michael Ross, MD – nothing to disclose

Molly Fisher, DO – nothing to disclose

Mehul Tejani, MD – nothing to disclose

Meredith Greene, MD – grant funding from Gilead Sciences, Inc.

Brian Wood, MD – nothing to disclose

Daniel Lee, MD – consulting fees from Gilead Sciences, Inc, ViiV Healthcare, Janssen Therapeutics, Theratechnologies; fees for Non-CME/CE Services Directly from a Commercial Interest or their Agent: Gilead Sciences, Inc, ViiV Healthcare, Merck Pharmaceuticals, Theratechnologies; Independent Contractor: ViiV Healthcare

James Scott, PharmD – nothing to disclose

Brandon Samson, PharmD, MPW – nothing to disclose

Charlie Smigelski, BA, BS, RD – nothing to disclose

Marshall Forstein, MD – nothing to disclose

Pariya Fazeli Wheeler, PhD – nothing to disclose

Karl Goodkind, MD, PhD – nothing to disclose

David E. Vance, PhD, MGS – nothing to disclose


The PIM planners and others have nothing to disclose. The American Academy of HIV Medicine planners and others have nothing to disclose.

Method of Participation and Request for Credit

In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:

  1. Go to www.cmeuniversity.com
  2. Login or Create a New Account (will take less than 1 minute)
    1. If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
    2. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
  3. Type in 16415 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
  4. Click on the activity title when it appears
  5. Choose the type of credit you desire
  6. Complete the Post-test with a passing score of 75% or better
  7. Complete the online Evaluation
  8. Receive an immediate CE Certificate to download and/or print for your files

For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.

If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and American Academy of HIV Medicine.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designation

Chapter 1 – Assessing Frailty and Functional Capacity: Managing the care of older adults with HIV

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2802-H02-P)

Type of Activity: Knowledge

 

Chapter 2 – Detection and Screening for HIV in Older Adults

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2803-H02-P)

Type of Activity: Knowledge

 

Chapter 3 – When to Initiate Antiretrovial Therapy and Monitoring in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2804-H02-P)

Type of Activity: Knowledge

 

Chapter 4 – Immunizations in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2805-H02-P)

Type of Activity: Knowledge

 

Chapter 5 – CVD Screening and Prevention

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2806-H02-P)

Type of Activity: Knowledge

 

Chapter 6 – Chronic Obstructive Pulmonary Disease in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2807-H02-P)

Type of Activity: Knowledge

 

Chapter 7 – Smoking

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2808-H02-P)

Type of Activity: Knowledge

 

Chapter 8 – The Kidney in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2809-H02-P)

Type of Activity: Knowledge

 

Chapter 9 – Hypertension in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2810-H02-P)

Type of Activity: Knowledge

 

Chapter 10 – Cancer in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2811-H02-P)

Type of Activity: Knowledge

 

Chapter 11 – Viral Hepatitis

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2812-H02-P)

Type of Activity: Knowledge

 

Chapter 12 – Diabetes Mellitus in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2813-H02-P)

Type of Activity: Knowledge

 

Chapter 13: Drug-Drug Interactions and Polypharmacy in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2814-H02-P)

Type of Activity: Knowledge

 

Chapter 14 – Osteoporosis in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2815-H02-P)

Type of Activity: Knowledge

 

Chapter 15 – Sexual Health

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2816-H02-P)

Type of Activity: Knowledge

 

Chapter 16 – PrEP and the Older Adult with HIV

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2817-H02-P)

Type of Activity: Knowledge


Chapter 17 – Nutrition

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2818-H02-P)

Type of Activity: Knowledge

 

Chapter 18 – Depression in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2819-H02-P)

Type of Activity: Knowledge

 

Chapter 19 – Anxiety Disorders in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2820-H02-P)

Type of Activity: Knowledge

 

Chapter 20 – Substance Use Disorders

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2821-H02-P)

Type of Activity: Knowledge

 

Chapter 21 – HIV-1 Associated Peripheral Neuropathologies in HIV and Aging

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2822-H02-P)

Type of Activity: Knowledge

 

Chapter 22 – Older Age and Associated Neurocognitive Disorder (HAND)

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2823-H02-P)

Type of Activity: Knowledge

 

Chapter 23 – Advanced Care Planning

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-21-2824-H02-P)

Type of Activity: Knowledge

 

Computer System Requirements

Internet Web Browser (Google Chrome, Firefox, Microsoft Edge, Internet Explorer)

 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

 

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development.  The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Updated on: 
Thursday, June 10, 2021

Purpose of this Program: The AAHIVM, ACRIA and AGS (collectively, the “Sponsors,” “we” or “us”) are sponsors of this Website and through it seek to address the unique needs and challenges that older adults of diverse populations living with HIV face as they age. However, the information in this Website is not meant to supplant the advice provided in a doctor-patient relationship.

General Disclaimer: HIV-Age.org is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through HIV-Age.org should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.

 

Connect

Phone: 202-659-0699
Fax: 202-659-0976

Contact

AAHIVM National Office
1627 Eye St NW Suite 835
Washington, D.C. 20006

About

The American Academy of HIV Medicine is a professional organization that supports the HIV practitioner and promotes accessible, quality care for all Americans living with HIV disease. Our membership of HIV practitioners and credentialed HIV Specialists™, HIV Experts™, and HIV Pharmacists™ provide direct care to the majority of HIV patients in the US.